Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20250526065900N1Phase 3Completed
Phase 3, randomised, double-blind trial in migraine comparing Mirtazapine arm with Topiramate arm (2 arms). Primary endpoint: Headache severity score based on MIDAS questionnaire. Started Aug 2026; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20250526065900N1.